Furthermore, it has been demonstrated that tau proteins could support neurovascular pathology in AD through mitochondrial dysregulation and ROS production [20] and, conversely, in murine models of AD, the inactivation of eNOS (APP/preselinin/eNOS−/−) increases intraneuronal tau phosphorylation [21]. The gene discussed is MAPT; the disease is Alzheimer disease.